603334 N丰倍生物
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--000
投资性房地产0--000
固定资产277,191106.48%134,248139,93888,227
在建工程142,734-51.09%291,805262,705155,847
无形资产58,440-2.21%59,76361,14350,849
商誉0--000
其他非流动资产20,007-3.64%20,76319,55730,197
498,372-1.62%506,579483,343325,120

流动资产
货币资金106,015-36.44%166,785156,745217,734
应收账款198,49149.06%133,16058,46796,794
存货368,41552.23%242,007198,383104,236
其他流动资产264,56140.56%188,225154,510193,938
937,48228.39%730,176568,105612,702

流动负债
短期借款259,60549.72%173,391141,531159,276
应付票据64,39270.29%37,81346,71959,776
应付帐款74,749-0.73%75,29887,96157,407
其他流动负债68,592-4.78%72,03260,43196,685
467,33930.35%358,535336,642373,144
流动资产净值470,14426.50%371,641231,463239,559
资产总额减流动负债968,51610.28%878,221714,806564,679

非流动负债
长期借款80,190-24.61%106,37072,90040,500
应付债券0--000
其他非流动负债13,354-16.84%16,05912,40410,762
93,544-23.59%122,42985,30451,262

总权益
    实收股本107,6000.00%107,600107,600107,600
    储备项目767,37218.39%648,191521,902405,817
股东权益874,97215.77%755,791629,502513,417
非控股权益0--000